Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14
Review
New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,557 | Dovepress* | 11,017+ | 1,783 | 12,800 | |
| PubMed Central* | 2,540 | 850 | 3,390 | ||
| Totals | 13,557 | 2,633 | 16,190 | ||
| *Since 23 April 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 1 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar